Image Guided Surgery Devices

Global Image Guided Surgery Devices Market to Reach US$6.8 Million by 2030

The global market for Image Guided Surgery Devices estimated at US$5.6 Million in the year 2024, is expected to reach US$6.8 Million by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Cardiac Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Million by the end of the analysis period. Growth in the Neurosurgery segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Million While China is Forecast to Grow at 3.0% CAGR

The Image Guided Surgery Devices market in the U.S. is estimated at US$1.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Million by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Image Guided Surgery Devices Market - Key Trends & Drivers Summarized

Image guided surgery devices have revolutionized the field of surgery by enhancing precision and improving patient outcomes. These advanced devices utilize imaging technologies such as MRI, CT scans, and ultrasound to provide real-time visual guidance during surgical procedures. This integration allows surgeons to navigate complex anatomies with greater accuracy, reducing the risk of complications and enhancing the success rate of surgeries. Image guided surgery devices are particularly beneficial in minimally invasive procedures, where the ability to visualize internal structures without large incisions leads to quicker recovery times and less postoperative pain for patients.

Recent trends in the image guided surgery market highlight significant advancements and innovations. There is a growing adoption of robotic-assisted surgical systems, which leverage image guidance to perform highly precise and controlled movements. This trend is driven by the increasing demand for minimally invasive surgeries and the push for better patient outcomes. Additionally, the development of portable and compact imaging devices is making image guided surgery more accessible in diverse healthcare settings, including smaller hospitals and outpatient facilities. The integration of artificial intelligence and machine learning algorithms is also enhancing the capabilities of these devices, allowing for better interpretation of imaging data and more precise surgical planning.

The growth in the image guided surgery devices market is driven by several factors. One of the primary drivers is the rising prevalence of chronic diseases and the subsequent increase in surgical procedures. As the global population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancer, and neurological disorders, all of which often require surgical intervention. Technological advancements, including the development of more sophisticated imaging modalities and the incorporation of AI, are also propelling market growth. Furthermore, there is a growing preference among surgeons and patients for minimally invasive procedures due to their benefits in terms of reduced recovery times and lower risk of complications. Increased healthcare spending and improved healthcare infrastructure, particularly in emerging economies, are making these advanced surgical technologies more widely available, further driving market expansion.

SCOPE OF STUDY:

The report analyzes the Image Guided Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Device Type (Endoscopes, Magnetic Resonance Imaging (MRI), Ultrasound Systems, Computed Tomography (CT) Scanners, X-ray Fluoroscopy, Other Device Types); Application (Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, Other Applications); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics, Research & Academic Institutes)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 212 Featured) -

• 7D Surgical Inc.
• Abbott Laboratories
• Accuray Incorporated
• Allengers
• Analogic Corporation
• Brainlab AG
• FUJIFILM Holdings Corporation
• GE HealthCare
• IMRIS, Deerfield Imaging, Inc.
• KARL STORZ SE & Co. KG
• Koninklijke Philips N.V.
• Medtronic plc
• Nanjing Perlove Medical Equipment Co., Ltd.
• Olympus Corporation
• OnLume Inc.
• Quest Medical Imaging B.V.
• Siemens Healthineers AG
• Stryker Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.